✦ LIBER ✦

Benefit, rather than safety, of cilostazol for long-term mortality in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trials

✍ Scribed by Hisato Takagi; Takuya Umemoto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DOES TRIPLE THERAPY WITH CILOSTAZOL DECR

✍ Amita Singh; Frederick Feit; Sripal Bangalore 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 190 KB

DOES TRIPLE THERAPY WITH CILOSTAZOL REDU

✍ Amita Singh; Michael Fingerhood; Frederick Feit; Sripal Bangalore 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Efficacy of Short-Term High-Dose Atorvas

✍ Liu, Yangchun; Su, Qiang; Li, Lang 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 650 KB

Efficacy and safety of zotarolimus-eluti

✍ Fan, Jinqi; Du, Huaan; Yin, Yuehui; Ling, Zhiyu; Wu, Jinjin; Xiao, Peilin; Zrenn 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 916 KB

Bivalirudin provides increasing benefit

✍ Derek P. Chew; Deepak L. Bhatt; Peter B. Berger; Tim Henry; Peter A. McCullough; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Comparison of Sirolimus- and Paclitaxel-

✍ Yong-le Li; Zheng Wan; Wen-li Lu; Jian-hua Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB